Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 12.42M $69.92M Dec. 31, 2013
FMR 6.91M $44.93M March 31, 2014
Partner Fund Management 5.13M $33.34M March 31, 2014
BlackRock Fund Advisors 4.32M $28.10M March 31, 2014
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
STATE STREET CORPORATION 4.24M $27.56M March 31, 2014
FIRST MANHATTAN 4.21M $27.37M March 31, 2014
Franklin Resources 4.03M $26.18M March 31, 2014
Bank of America Corporation 3.38M $21.95M March 31, 2014
BlackRock Institutional Trust Company, N.A. 2.98M $19.36M March 31, 2014
Vanguard 2.96M $19.22M March 31, 2014
Farallon Capital Management 2.68M $17.45M March 31, 2014
T. Rowe Price Associates 2.63M $17.12M March 31, 2014
Millennium Management 2.36M $15.33M March 31, 2014
RS INVESTMENT MANAGEMENT 2.22M $14.45M March 31, 2014
FIL 2.21M $14.34M March 31, 2014
Meditor 2.10M $12.87M Sept. 30, 2013
NEA Management Company 1.94M $12.58M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.79M $11.59M March 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.79M $11.61M March 31, 2014
FRED ALGER MANAGEMENT 1.78M $11.57M March 31, 2014
Visium Asset Management 1.67M $9.77M June 30, 2013
Palo Alto Investors 1.67M $10.85M March 31, 2014
SUSQUEHANNA INTERNATIONAL 1.65M $10.68M March 31, 2014
D. E. Shaw & Co 1.55M $8.72M Dec. 31, 2013
NORTHERN TRUST 1.39M $9.02M March 31, 2014
Diamondback Capital Management 1.38M $7.63M June 30, 2012
CITADEL ADVISORS 1.35M $8.26M Sept. 30, 2013
QVT Financial 1.32M $8.60M March 31, 2014
Foresite Capital Management I 1.25M $8.12M March 31, 2014
Jennison Associates 1.23M $7.66M March 31, 2013
Redmile 1.19M $6.95M June 30, 2013
Columbus Circle Investors 1.06M $6.51M Sept. 30, 2013
Hudson Bay Capital Management 1.00M $5.64M Dec. 31, 2013
Apex Capital 1000000 $5.63M Dec. 31, 2013
STIFEL FINANCIAL 996424 $6.49M March 31, 2014
CR Intrinsic Investors 954604 $5.58M June 30, 2013
Charles Schwab Investment Management 954600 $5.08M June 30, 2012

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Adage Capital Partners GP March 31, 2013 1.20M $7.51M
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M
BAM Capital Dec. 31, 2010 948131 $7.66M